Loading…
Disclosed for 9 months, Jan 2026 to Sep 2026.Published as: TATA INDIA PHARMA & HEALTHCARE FUND
Tata India Pharma & Healthcare Fund is an active equity fund in the Sectoral / Thematic category from Tata Mutual Fund. In September 2026 it disclosed 42 stocks worth ₹1,511 Cr, down ₹53.8 Cr from Aug 2026. Its largest positions were Sun Pharmaceutical Industries Limited (8.0%), Abbott India Limited (5.9%), Healthcare Global Enterprises Limited (5.9%); the ten largest together made up 50.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 60.8% of its equity. Cash and debt stood at 0.3%. Compared with Aug 2026 the fund entered 4 new stocks and exited 3.
Top-10 weight is higher than 61% of peers
Holds more stocks than 46% of peers
Holds more cash than 4% of peers
Every line the fund disclosed, with the change against Aug 2026. Click a column to sort; click a company to see every fund that owns it.
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Aug 2026, the weight rose most in Chemicals & Petrochemicals (+2.6 pts) and Pharmaceuticals & Biotechnology (+2.2 pts), and fell most in Healthcare Services (−5.5 pts) and Insurance (−0.5 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 58.9% | 61.3% | 58.6% | 60.8% |
| Healthcare Services | 35.5% | 33.2% | 33.4% | 27.9% |
| Fertilizers & Agrochemicals | 4.5% | 4.3% | 5.6% | 6.9% |
| Chemicals & Petrochemicals | 0.5% | — | — | 2.6% |
| Personal Products | — | 1.3% | 1.1% | 1.2% |
| Healthcare Equipment & Supplies | — | — | 0.9% | 0.5% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| ₹1,325 Cr |
| 37 |
| 0 |
| 1 |
| 0.4% |
| 0.4% |
| 88% |
| Mar 2026 | ₹1,229 Cr | 38 | 6 | 2 | 0.3% | 0.3% | 61% |
| Feb 2026 | ₹1,301 Cr | 34 | 0 | 0 | 2.4% | 2.4% | 59% |
| Jan 2026 | ₹1,240 Cr | 34 | 0.9% | 0.9% | 71% |